FDA label
What is Aptiom used for?
Aptiom contains eslicarbazepine acetate. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “APTIOM is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Aptiom?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Aptiom, tablet
Indications and Usage, quoted from the label by Sumitomo Pharma America, Inc. (NDA022416). Cross-references to other label sections are left out.
APTIOM is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Source: DailyMed label, set id 3d0c9554-eaeb-4694-8089-00133fcadce3, version 16, effective November 10, 2023. NDC 63402-202, one of 4 listings for this product.
Questions
What is Aptiom used for?
The FDA label says: “APTIOM is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.